Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor microenvironment-adaptive nanocatalysts: harnessing pH gradients for selective and synergistic cancer therapy.

Journal of materials chemistry. B·2026
Same author

Long-Acting Dynamic Therapy Using X-Ray Activated Organic Nanoparticles for Afterglow Imaging Guided Deep Tumor Treatment.

Angewandte Chemie (International ed. in English)·2026
Same author

Long-Acting Fractionated Sonodynamic Therapy Enabled by Fused-Trianthracene Nanoparticles with Ultra-Bright Ultrasound-Induced Afterglow Luminescence.

Journal of the American Chemical Society·2026
Same author

Neutrophil elastase-activatable ratiometric photoacoustic nanoprobes for imaging atherosclerotic plaque vulnerability.

Nature communications·2025
Same author

Chlorine Radical-Driven, Oxygen-Independent Afterglow Nanoplatform for Tumor Microenvironment-Adaptive Imaging and Therapy.

Angewandte Chemie (International ed. in English)·2025
Same author

Three-Dimensional Afterglow Luminescence-MRI Fusion Tomography with Magnetically Targeted Luminescent-Magnetic Nanoparticles for Deep-Seated Tumor Imaging.

ACS nano·2025

Related Experiment Video

Updated: Jul 20, 2025

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

1.5K

Emerging biomedical imaging-based companion diagnostics for precision medicine.

Shiyi Liao1, Mengjie Zhou1, Youjuan Wang1

  • 1State Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, China.

Iscience
|July 31, 2023
PubMed
Summary

Companion diagnostics (CDx) paired with molecular imaging can overcome limitations of current tests. This approach enables dynamic in vivo monitoring of tumor heterogeneity and treatment response for precision medicine.

Keywords:
Biomedical engineeringDiagnostics

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Related Experiment Videos

Last Updated: Jul 20, 2025

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

1.5K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Area of Science:

  • Oncology
  • Medical Imaging
  • Molecular Diagnostics

Background:

  • Tumor heterogeneity impacts prognosis and treatment efficacy.
  • Current companion diagnostics (CDx) primarily use in vitro/ex vivo methods, limiting dynamic in vivo monitoring.
  • In vivo monitoring is crucial for assessing dynamic changes in tumor microenvironments.

Purpose of the Study:

  • To review advancements in molecular imaging for predicting and assessing cancer therapy response.
  • To highlight biomarkers used in imaging-based CDx tests.
  • To explore the role of imaging-based CDx in advancing precision medicine.

Main Methods:

  • Review of recent developments in molecular imaging techniques.
  • Analysis of biomarkers utilized in imaging-based companion diagnostics.
  • Discussion of the integration of imaging with companion diagnostics for cancer therapy.

Main Results:

  • Molecular imaging offers dynamic measurement of tumor heterogeneity and treatment response.
  • Imaging-based CDx can complement traditional CDx tests by providing in vivo data.
  • Patient stratification and identification of treatment benefits are enhanced through imaging-based approaches.

Conclusions:

  • Imaging-based companion diagnostics represent a significant advancement in precision oncology.
  • This approach facilitates dynamic monitoring of therapeutic responses and tumor heterogeneity.
  • Further development in this field promises to improve patient outcomes and personalize cancer treatment.